Shorter reflections, LinkedIn series, and commentary on events, trends, and questions we encounter in our daily work. With the occasional book spotlight. Think of this as our notebook — where ongoing questions meet fresh observations.
Under Construction: What the Cologne Cathedral Teaches Us About Change
For me, the Cologne Cathedral is more than just a landmark. It stands for history, for transformation – and for resilience. Over the past decades, I’v…
Gene Therapy in Neurology – Opportunities for Family Offices
Neurological diseases remain one of the most pressing areas of unmet medical need. For many rare or monogenic disorders of the central nervous system …
What restoring a classic car taught me about negotiations
I’ve been restoring classic cars for years – currently a Mercedes R107. Along the way, I realized how similar the process is to preparing for high-sta…
Spotting the Next Gullwing: How to Distinguish Breakthrough Biotech from Concept Hype
I’ve always admired the Mercedes 300 SL Gullwing. This wasn’t just a beautiful car – it represented radical engineering leaps. Fuel injection, lightwe…
3 common mistakes in pharma market access negotiations – and how to avoid them
Market access is often the decisive bottleneck: without successful payer negotiations, even the most innovative product will fail commercially. From m…
Asia-Pacific BioPharma Insights
Country Spotlight Series: Japan Biotech & Pharma Deep Dive Market Overview Japan is one of the most mature and innovation-driven biotech and pharm…